<i>In‐vitro</i> evaluation of a ciprofloxacin and azithromycin sinus stent for <i>Pseudomonas aeruginosa</i> biofilms

Abstract

The CASS maintains a uniform coating and sustained delivery of ciprofloxacin and azithromycin, providing anti-biofilm activities against P aeruginosa. Further studies evaluating the efficacy of CASS in a preclinical model are planned.